Skip to main content
Journal ArticleOPEN ACCESS

Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer

Cochrane Database of Systematic Reviews (2017) 2017(9)
DOI: 10.1002/14651858.CD012816
27Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of immediate taxane-based chemohormonal therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.

Cite

CITATION STYLE

APA

Sathianathen, N. J., Philippou, Y. A., Kuntz, G. M., Konety, B. R., Lamb, A. D., & Dahm, P. (2017). Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer. Cochrane Database of Systematic Reviews, 2017(9). https://doi.org/10.1002/14651858.CD012816

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free